powerpoint presentation€¦ · angina pectoris mutations in ldl receptor, apolipoprotein b or...

25

Upload: others

Post on 23-Oct-2020

4 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

•• ≥ ≥

• ≥ ≥

•

•

•
•

•

•
•

•

•

Nordestgaard et al. Eur Heart J 2013; 34: 3478-3490

Plasma Lipids, lipoprotein & Apolipoprotein Proteins

Cardiovascular Franchise: Multiple Approaches to ...€¦ · Targeting PCSK9 for Lipid Management PCSK9 mRNA Reduction Correlates with LDL-C Lowering in Preclinical Studies PCSK9

Treatment of Severe FH Forms: PCSK9 Inhibitors · 2020. 2. 13. · Conclusions: PCSK9 inhibitors in FH •Very effective in HeFH •TAUSSIG: •Evolocumab reasonable and variable

Clusterin/Apolipoprotein J immunoreactivity is associated

I (OR MY FAMILY MEMBER) AM READY TO GET ......as cholesterol absorption inhibitors (eg, ezetimibe) and PCSK9 inhibitors. Switching to another medication helped this FH patient to maintain

2012/11 - IR - PCSK9

Novel Therapeutic Target of PCSK9

PCSK9 Inhibitors

Guia prático para a utilização dos inibidores da PCSK9 em ... · inibidores da PCSK9 são anticorpos monoclonais que se ligam à PCSK9 impedindo-a de se ligar ao recetor do LDL,

Further cardiovascular OUtcomes Research with PCSK9

PCSK9 Inhibitors PP

for apolipoprotein(a)

Accumulationof Apolipoprotein E-rich HighDensity

PCSK9 Inhibition : From Genetics to Patients · PCSK9 mutations and impact on LDL-C\爀屲 PCSK9 mutations represent the major source of variability in PCSK9 expression. Two type\൳

MODUL PRAKTIKUM PEMERIKSAAN ELISA APOLIPOPROTEIN E

Serum apolipoprotein B/apolipoprotein A1 ratio in relation

PCSK9 Loss-of-function Mutations

User Manual (Sandwich CLIA ) Apolipoprotein B CLIA Kit ... · Apolipoprotein B, FLDB, LDLCQ4, Mutant Apo B 100, Apo B-100, Apolipoprotein B-100, Apolipoprotein B48 Specificity : This

Facilitating Patient Access To PCSK9 Inhibitors

APOLIPOPROTEIN E4 ALLELE IS ASSOCIATED WITH …

in vitro de variantes no gene PCSK9 identificadas em ...€¦ · PCSK9, primeiramente foi avaliado o impacto dessas variantes na interação PCSK9-LDLR via Docking molecular. Células

IDENTIFICATION OF INHIBITORS FOR PCSK9

Update on PCSK9 Inhibitors

Inibidores da PCSK9 no tratamento de doenças ... · PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review Inibidores da PCSK9 no tratamento de doenças

PCSK9...Bryan Heart Fall Conference 2015 PCSK9 Inhibitors Current Status Title Microsoft PowerPoint - PCSK9.pptx Author tlw011 Created Date 9/2/2015 3:31:45 PM

Functional analyses of human apolipoprotein CII by site ... · Abbreviations used: ApoCII, apolipoprotein CII; ApoAI, apolipoprotein AI; CD, circular dichroism; GdmCl, guanidinium

Apolipoprotein E Deficiency Increases Remnant Lipoproteins ... › ws › files › 139329962 › befo_1_s2.0_S2… · experimental atherosclerosis is the apolipoprotein E (APOE)–deﬁcient

An altered pattern of circulating apolipoprotein E3 ... · An altered pattern of circulating apolipoprotein E3 ... An altered pattern of circulating apolipoprotein E3 isoforms is

Further cardiovascular OUtcomes Research with PCSK9 ...clinicaltrialresults.org/Slides/ACC2017/Fourier_Sabatine.pdf · Further cardiovascular OUtcomes Research with PCSK9 Inhibition

APOLIPOPROTEIN E SEBAGAI FAKTOR RISIKO TIMBULNYA …

NOVA ABORDAGEM TERAPÊUTICA PARA DISLIPIDEMIAS: PCSK9€¦ · 4.6 PRÓ-PROTEÍNA CONVERTASE SUBTILISINA KEXINA TIPO 9 - PCSK9 40 4.6.1 Mecanismo de ação da PCSK9 42 4.6.2 Mutações

Plasma Lipoproteins: Apolipoprotein structure and Function

Preparing for a Novel Era in CV Prevention: Where do PCSK9 ... · CV Prevention: Where do PCSK9 Inhibitors Fit in Lipid Management Prof. John J.P. Kastelein, MD PhD FESC ... PCSK9

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

APOLIPOPROTEIN E SEBAGAI FAKTOR.pdf